4.3 Article Proceedings Paper

Chemical biology of tetracycline antibiotics

出版社

CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
DOI: 10.1139/O08-002

关键词

antibiotic; tetracycline; biosynthesis; resistance

向作者/读者索取更多资源

For more than half a century, tetracycline antibiotics have been used to treat infectious disease. However, what once used to be a commonly prescribed family of antibiotics has now decreased in effectiveness due to wide-spread bacterial resistance. The chemical scaffold of the tetracyclines is a versatile and modifiable structure that is able to interact with many cellular targets. The recent availability of detailed molecular interactions between tetracycline and its cellular targets, along with an understanding of the tetracycline biosynthetic pathway, has provided us with a unique opportunity to usher in a new era of rational drug design. Herein we discuss recent findings that have clarified the mode of action and the biosynthetic pathway of tetracyclines and that have shed light on the chemical biology of tetracycline antibiotics.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

GPAHex-A synthetic biology platform for Type IV-V glycopeptide antibiotic production and discovery

Min Xu, Wenliang Wang, Nicholas Waglechner, Elizabeth J. Culp, Allison K. Guitor, Gerard D. Wright

NATURE COMMUNICATIONS (2020)

Article Genetics & Heredity

Identifying novel β-lactamase substrate activity through in silico prediction of antimicrobial resistance

Kara K. Tsang, Finlay Maguire, Haley L. Zubyk, Sommer Chou, Arman Edalatmand, Gerard D. Wright, Robert G. Beiko, Andrew G. McArthur

Summary: By generating and applying predictive models, this study identified previously unknown beta-lactamase substrate activities, which can help guide researchers in understanding the mechanisms of resistance.

MICROBIAL GENOMICS (2021)

Review Chemistry, Multidisciplinary

The Antibiotic Resistome: A Guide for the Discovery of Natural Products as Antimicrobial

Christian Hobson, Andrew N. Chan, Gerard D. Wright

Summary: The ongoing challenge of antibiotic resistance is a formidable threat towards the discovery and use of traditional antibiotics. The study and understanding of molecular mechanisms in the resistome provide a basis for the genomics-driven discovery and development of novel antimicrobials to combat emerging pathogens that are resistant to even the newest approved therapies.

CHEMICAL REVIEWS (2021)

Article Microbiology

ApmA Is a Unique Aminoglycoside Antibiotic Acetyltransferase That Inactivates Apramycin

Emily Bordeleau, Peter J. Stogios, Elena Evdokimova, Kalinka Koteva, Alexei Savchenko, Gerard D. Wright

Summary: Apramycin, an aminoglycoside antibiotic, has a unique structure and resistance mechanism, making it a promising candidate in combating multidrug-resistant pathogens.
Review Chemistry, Multidisciplinary

The Enzymes of the Rifamycin Antibiotic Resistome

Matthew D. Surette, Peter Spanogiannopoulos, Gerard D. Wright

Summary: Rifamycin antibiotics, including rifampin, rifabutin, and rifapentine, are derived from natural rifamycins and primarily used to treat mycobacterial infections such as tuberculosis. These antibiotics inhibit bacterial RNA polymerase by binding to the beta-subunit, leading to cell death. Resistance to rifamycin antibiotics mainly arises from point mutations in RNA polymerase among clinical strains, while environmental mycobacteria and actinomycetes show a richer and diverse rifamycin resistome with various enzymatic mechanisms.

ACCOUNTS OF CHEMICAL RESEARCH (2021)

Article Chemistry, Medicinal

A Screen of Natural Product Extracts Identifies Moenomycin as a Potent Antigonococcal Agent

Venkateswarlu Yarlagadda, Vishwas N. Rao, Manpreet Kaur, Allison K. Guitor, Gerard D. Wright

Summary: The increasing multidrug resistance in Neisseria gonorrheae is a growing public health crisis. Moenomycin, identified from a screen of microbial natural products, shows excellent activity against multidrug-resistant N. gonorrheae and has the potential to be a lead for antigonococcal therapeutic candidates.

ACS INFECTIOUS DISEASES (2021)

Review Chemistry, Multidisciplinary

Prospects for Antibacterial Discovery and Development

Thomas M. Privalsky, Alexander M. Soohoo, Jinhua Wang, Christopher T. Walsh, Gerard D. Wright, Eric M. Gordon, Nathanael S. Gray, Chaitan Khosla

Summary: The increasing prevalence of multidrug-resistant bacteria has become an urgent health crisis, requiring renewed investment in the discovery and development of antibiotics. A multifaceted approach is necessary to address the antibacterial resistance crisis, with a focus on exploring validated antibacterial targets and lead molecules. Creative techniques, such as studying underexplored ecological niches or utilizing available data from genome mining efforts, can help in the search for new antibiotic leads.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)

Article Chemistry, Multidisciplinary

Three-Dimensional Structure and Optimization of the Metallo-β-Lactamase Inhibitor Aspergillomarasmine A

Kalinka Koteva, David Sychantha, Caitlyn M. Rotondo, Christian Hobson, James F. Britten, Gerard D. Wright

Summary: This study reports the crystal structure of a natural metallophore and MBL inhibitor, AMA, and synthesizes 23 novel analogs. In vitro evaluation shows three analogs with favorable characteristics that can be further developed into more potent and broader-spectrum MBL inhibitors.

ACS OMEGA (2022)

Article Chemistry, Multidisciplinary

Phylogeny-Informed Synthetic Biology Reveals Unprecedented Structural Novelty in Type V Glycopeptide Antibiotics

Min Xu, Wenliang Wang, Nicholas Waglechner, Elizabeth J. Culp, Allison K. Guitor, Gerard D. Wright

Summary: The rise and dissemination of glycopeptide antibiotic (GPA)-resistant pathogens in healthcare settings have driven efforts to discover new GPAs that can overcome resistance. In this study, a phylogeny-guided genome mining strategy and heterologous production using the GPAHex synthetic biology platform were used to characterize five newly discovered type V GPAs. These GPAs demonstrated potent activity against GPA-resistant clinical isolates and their mode of action was consistent with the inhibition of cell division by evading autolysin activity. This research expands the chemical diversity of GPAs, offers new drug development prospects, and showcases the potential of the GPAHex platform in mining GPA chemical dark matter.

ACS CENTRAL SCIENCE (2022)

Article Microbiology

ClpP inhibitors are produced by a widespread family of bacterial gene clusters

Elizabeth J. Culp, David Sychantha, Christian Hobson, Andrew C. Pawlowski, Gerd Prehna, Gerard D. Wright

Summary: A widespread family of bacterial ClpP-associated gene clusters has been identified, which produce specific compounds that selectively inhibit ClpP enzyme activity and may play an important role in bacterial competition.

NATURE MICROBIOLOGY (2022)

Review Cell Biology

The past, present, and future of antibiotics

Michael A. Cook, Gerard D. Wright

Summary: Antibiotics have played a crucial role in modern medicine, but they are facing challenges of microbial resistance and traditional reimbursement models. Therefore, innovation is needed in policy, quantitative understanding of societal value, and investment in alternatives. Significant investment in research and development is also necessary to address the antibiotic crisis.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Chemistry, Medicinal

Synthetic Biology Facilitates Semisynthetic Development of Type V Glycopeptide Antibiotics Targeting Vancomycin-Resistant Enterococcus

Kalinka Koteva, Min Xu, Wenliang Wang, Aline A. Fiebig-Comyn, Michael A. Cook, Brian K. Coombes, Gerard D. Wright

Summary: The continued efficacy of glycopeptide antibiotics is threatened by the emergence and spread of resistant pathogens, especially vancomycin-resistant enterococci. This study modified a Type V glycopeptide antibiotic, rimomycin A, to generate 32 new analogues. Compound 17, derived from rimomycin A through N-terminal acylation and C-terminal amidation, showed improved activity against VRE and increased solubility. In a mouse model of VRE infection, compound 17 significantly reduced bacterial load. This study paves the way for the development of next-generation glycopeptide antibiotics in response to the growing problem of VRE infections.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Biotechnology & Applied Microbiology

Lessons from assembling a microbial natural product and pre-fractionated extract library in an academic laboratory

Michael A. Cook, Daniel Pallant, Linda Ejim, Arlene D. Sutherland, Xiaodong Wang, Jarrod W. Johnson, Susan Mccusker, Xuefei Chen, Maya George, Sommer Chou, Kalinka Koteva, Wenliang Wang, Christian Hobson, Dirk Hackenberger, Nicholas Waglechner, Obi Ejim, Tracey Campbell, Ricardo Medina, Lesley T. Macneil, Gerard D. Wright

Summary: Microbial natural products are rich sources of bioactive compounds, but the pharmaceutical industry is shifting towards synthetic compounds due to the repeated rediscovery of known compounds. However, the development of advanced mass spectrometry tools and genomics provides opportunities to revisit microbial natural product libraries.

JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY (2023)

Article Microbiology

Angucyclinones rescue PhLOPSA antibiotic activity by inhibiting Cfr-dependent antibiotic resistance

Adam J. Schaenzer, Annia Rodriguez Hernandez, Kaitlyn Tsai, Christian Hobson, Danica Galonic Fujimori, Gerard D. Wright

Summary: This study identifies the compounds MTN and MTL from Streptomyces WAC01849 that selectively potentiate the activity of PhLOPSA antibiotics in a Cfr-dependent manner. Furthermore, these compounds inhibit Cfr-mediated ribosome methylation, suggesting their potential as Cfr inhibitors for the development of clinically useful antibiotics.
Article Biochemistry & Molecular Biology

Mechanistic plasticity in ApmA enables aminoglycoside promiscuity for resistance

Emily Bordeleau, Peter J. Stogios, Elena Evdokimova, Kalinka Koteva, Alexei Savchenko, Gerard D. Wright

Summary: The efficacy of aminoglycoside antibiotics is decreasing due to the emergence of resistance mechanisms in bacteria. In this study, the authors identify a new enzyme, ApmA, that confers broad-spectrum aminoglycoside resistance through a unique molecular mechanism. They also discover additional clinical drugs that are susceptible to modification by this enzyme, diverging from previous findings in the same enzyme family.

NATURE CHEMICAL BIOLOGY (2023)

暂无数据